Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE:300760)
China flag China · Delayed Price · Currency is CNY
179.40
+1.89 (1.06%)
Nov 13, 2026, 3:04 PM CST

SHE:300760 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Revenue
34,54633,28236,72634,93230,36625,270
Revenue Growth
4.45%-9.38%5.13%15.04%20.17%20.18%
Gross Profit
20,28719,75522,95922,16419,41016,303
Operating Income
9,7909,29912,37312,26110,4098,764
Net Income
7,7508,13611,66811,5829,6078,002
Earnings Per Share
6.406.719.639.567.946.59
EPS Growth
-9.95%-30.30%0.79%20.42%20.50%20.28%

Revenue by Geography

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingDec '25 Dec '24 Dec '23 Jan '23 Jan '22
China
15,63220,29221,38218,66715,259
Asian-Pacific
3,6183,6592,6382,2812,174
Europe
3,3742,8872,1911,9982,268
Latin America
2,9822,8042,4222,0971,568
North America
2,7022,6362,6032,4611,872
Others
4,9744,4463,6962,8622,129
Total
33,28236,72634,93230,36625,270

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Investments
19,85717,94116,64418,78723,18615,361
Total Debt
300.71349.28298.49294.93236.52237.24
Net Cash (Debt)
19,55717,59216,34618,49222,94915,124
Net Cash Growth
13.99%7.62%-11.61%-19.42%51.74%-4.67%
Net Cash Per Share
16.1414.5213.4915.2618.9612.45

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Cash Flow
11,16910,14512,43211,06212,1418,999
Capital Expenditures
-2,083-2,038-1,959-2,689-1,916-1,402
Free Cash Flow
9,0878,10710,4738,37310,2267,596
Free Cash Flow Growth
38.44%-22.59%25.07%-18.11%34.62%-1.19%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingSep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Gross Margin
58.72%59.36%62.51%63.45%63.92%64.52%
Operating Margin
28.34%27.94%33.69%35.10%34.28%34.68%
Pretax Margin
26.65%29.07%35.45%37.25%36.07%35.68%
Profit Margin
22.43%24.45%31.77%33.16%31.64%31.66%
FCF Margin
26.30%24.36%28.52%23.97%33.67%30.06%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Dividend Per Share
4.3804.3806.2705.8004.5003.500
Dividend Per Share Growth
-9.50%-30.14%8.10%28.89%28.57%40.00%
Dividend Yield
2.44%2.30%2.46%2.00%1.42%0.92%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingNov '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
PE Ratio
28.0528.3126.4330.3439.7857.71
Forward PE
23.3324.2822.3226.6834.8648.63
P/FCF Ratio
23.9328.4129.4541.9737.3760.79
PS Ratio
6.296.928.4010.0612.5818.27